Iovance Biotherapeutics, Inc. (IOVA)
4.595
+0.34
(+7.86%)
USD |
NASDAQ |
Mar 05, 16:00
4.58
-0.02
(-0.33%)
After-Hours: 19:34
Iovance Biotherapeutics Cash from Investing (Quarterly) : 0.775M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Orthofix Medical, Inc. | -10.86M |
| InfuSystem Holdings, Inc. | -2.192M |
| Axogen, Inc. | 4.042M |
| KalVista Pharmaceuticals, Inc. | -- |
| Lantheus Holdings, Inc. | -11.51M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -52.56M |
| Cash from Financing (Quarterly) | 56.17M |
| Free Cash Flow | -336.24M |
| Free Cash Flow Per Share (Quarterly) | -0.1521 |
| Free Cash Flow to Equity (Quarterly) | -58.84M |
| Free Cash Flow to Firm (Quarterly) | -61.88M |
| Free Cash Flow Yield | -20.49% |